FAAS
DMK

First Allied Advisory Services’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

First Allied Advisory Services’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-314
Closed -$114K – 1209
2017
Q2 		$114K Buy
+314
New +$94K 0.01% 1097

Other funds holding DMK

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $286M AUM 26.75% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

First Allied Advisory Services's DMK Position: Q3 2017 in Review

First Allied Advisory Services sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q3 2017, closing a stake of 314 shares — an estimated $114K sold.

First Allied Advisory Services first reported a position in DMK in Q2 2017 and held it in 1 quarter. The position peaked at $114K in Q2 2017. 46 funds tracked by Wall St. Rank hold DMK as of Q3 2017.

  • First Allied Advisory Services reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q3 2017 after selling out during the quarter.
  • First Allied Advisory Services sold 314 DMK Pharmaceuticals Corporation Common Stock shares in Q3 2017, an estimated $114K.
  • First Allied Advisory Services first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2017 and held it in 1 quarter.
  • First Allied Advisory Services's DMK Pharmaceuticals Corporation Common Stock position peaked at $114K in Q2 2017.
  • 46 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q3 2017.

Based on First Allied Advisory Services's 13F filing for Q3 2017, filed 14 Nov 2017.